These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 3907821)

  • 21. The present status of tumor immunology.
    Fisher B
    Adv Surg; 1971; 5():189-254. PubMed ID: 4941820
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunity to infection, allograft immunity and tumour immunity: parallels and contrasts.
    Nelson DS
    Transplant Rev; 1974; 19(0):226-54. PubMed ID: 4152202
    [No Abstract]   [Full Text] [Related]  

  • 23. [Basic characteristics of macrophage as an effector cell].
    Voĭtenkov BO; Okulov VB
    Vestn Ross Akad Med Nauk; 1995; (4):59-64. PubMed ID: 7780345
    [No Abstract]   [Full Text] [Related]  

  • 24. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance.
    Allavena P; Sica A; Garlanda C; Mantovani A
    Immunol Rev; 2008 Apr; 222():155-61. PubMed ID: 18364000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral infections in man associated with acquired immunological deficiency states.
    Merigan TC; Stevens DA
    Fed Proc; 1971; 30(6):1858-64. PubMed ID: 4333313
    [No Abstract]   [Full Text] [Related]  

  • 26. Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor.
    Mantovani A; Ming WJ; Balotta C; Abdeljalil B; Bottazzi B
    Biochim Biophys Acta; 1986 Aug; 865(1):59-67. PubMed ID: 2425851
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues.
    Bottazzi B; Polentarutti N; Balsari A; Boraschi D; Ghezzi P; Salmona M; Mantovani A
    Int J Cancer; 1983 Jan; 31(1):55-63. PubMed ID: 6403477
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of immune processes on the growth and regression of malignant tumors].
    Russo V; Russo L
    Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500
    [No Abstract]   [Full Text] [Related]  

  • 29. The biology of macrophages: II. Inflammation and tumors.
    Seljelid R; Busund LT
    Eur J Haematol; 1994 Jan; 52(1):1-12. PubMed ID: 8299765
    [No Abstract]   [Full Text] [Related]  

  • 30. Eradication of cancer metastasis by tumoricidal macrophages.
    Fidler IJ
    Adv Exp Med Biol; 1988; 233():415-23. PubMed ID: 3223395
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans.
    Topalian SL; Rosenberg SA
    Important Adv Oncol; 1990; ():19-41. PubMed ID: 2182519
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic control of natural cytotoxicity and hybrid resistance.
    Clark EA; Harmon RC
    Adv Cancer Res; 1980; 31():227-85. PubMed ID: 6157312
    [No Abstract]   [Full Text] [Related]  

  • 33. Convergent pathways of macrophage polarization: The role of B cells.
    Sica A; Porta C; Riboldi E; Locati M
    Eur J Immunol; 2010 Aug; 40(8):2131-3. PubMed ID: 20623553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immature myeloid cells and cancer-associated immune suppression.
    Kusmartsev S; Gabrilovich DI
    Cancer Immunol Immunother; 2002 Aug; 51(6):293-8. PubMed ID: 12111117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumorigenicity and dissemination of human tumors in congenitally immune-deficient mice.
    Fodstad O
    J Natl Cancer Inst; 1991 Oct; 83(19):1419-20. PubMed ID: 1920486
    [No Abstract]   [Full Text] [Related]  

  • 36. E-type prostaglandins and interferons: yin-yang modulation of macrophage tumoricidal activity.
    Schultz RM
    Med Hypotheses; 1980 Aug; 6(8):831-43. PubMed ID: 6160377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Subpopulations of human T-lymphocytes and their suppressor functions].
    Brondz BD
    Ter Arkh; 1980; 52(9):120-32. PubMed ID: 6449090
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tumor immunology].
    Milas L; Silobrcić V
    Lijec Vjesn; 1970; 92(1):5-33. PubMed ID: 4932237
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumour immunology: alternative perspectives.
    Seljelid R
    Scand J Immunol; 1997 Nov; 46(5):437-44. PubMed ID: 9393625
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotactic activity of the leukocytes in the neoplastic process].
    Dabrowski W; Braun J
    Pol Tyg Lek; 1981 Oct; 36(40):1561-4. PubMed ID: 7038643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.